WO1997038083A3 - New member of the multiple-tumor aberrant growth gene family - Google Patents

New member of the multiple-tumor aberrant growth gene family Download PDF

Info

Publication number
WO1997038083A3
WO1997038083A3 PCT/EP1997/001710 EP9701710W WO9738083A3 WO 1997038083 A3 WO1997038083 A3 WO 1997038083A3 EP 9701710 W EP9701710 W EP 9701710W WO 9738083 A3 WO9738083 A3 WO 9738083A3
Authority
WO
WIPO (PCT)
Prior art keywords
new member
gene family
aberrant growth
growth gene
tumor aberrant
Prior art date
Application number
PCT/EP1997/001710
Other languages
French (fr)
Other versions
WO1997038083A2 (en
Inventor
De Ven Willem Jan Marie Van
Original Assignee
Leuven K U Res & Dev
De Ven Willem Jan Marie Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven K U Res & Dev, De Ven Willem Jan Marie Van filed Critical Leuven K U Res & Dev
Priority to AU23838/97A priority Critical patent/AU2383897A/en
Priority to EP97919321A priority patent/EP0927194A2/en
Publication of WO1997038083A2 publication Critical patent/WO1997038083A2/en
Publication of WO1997038083A3 publication Critical patent/WO1997038083A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Abstract

The present invention relates to a new member of the multi-tumor Aberrant Growth (MAG) gene family located on the short arm of chromosome 3 and involved in a variety of benign and malignant tumors. The gene and its derivatives may be used in various diagnostic and therapeutic applications.
PCT/EP1997/001710 1996-04-04 1997-04-04 New member of the multiple-tumor aberrant growth gene family WO1997038083A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU23838/97A AU2383897A (en) 1996-04-04 1997-04-04 New member of the multiple-tumor aberrant growth gene family
EP97919321A EP0927194A2 (en) 1996-04-04 1997-04-04 New member of the multiple-tumor aberrant growth gene family

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96200966.8 1996-04-04
EP96200966 1996-04-04

Publications (2)

Publication Number Publication Date
WO1997038083A2 WO1997038083A2 (en) 1997-10-16
WO1997038083A3 true WO1997038083A3 (en) 1998-01-22

Family

ID=8223856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/001710 WO1997038083A2 (en) 1996-04-04 1997-04-04 New member of the multiple-tumor aberrant growth gene family

Country Status (3)

Country Link
EP (1) EP0927194A2 (en)
AU (1) AU2383897A (en)
WO (1) WO1997038083A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009865A1 (en) * 1989-12-22 1991-07-11 The Trustees Of Columbia University In The City Of New York Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof
WO1995025429A1 (en) * 1994-03-18 1995-09-28 Myriad Genetics, Inc. Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991009865A1 (en) * 1989-12-22 1991-07-11 The Trustees Of Columbia University In The City Of New York Purified myeloblastin, nucleic acid molecule encoding same, and uses thereof
WO1995025429A1 (en) * 1994-03-18 1995-09-28 Myriad Genetics, Inc. Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DAL CIN ET AL.: "Rearrangement of 12q14-15 in pulmonary chondroid hamartoma", GENES, CHROMOSOMES & CANCER, vol. 8, 1993, pages 131 - 133, XP002046941 *
OHTA ET AL.: "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers", CELL, vol. 84, 23 February 1996 (1996-02-23), pages 587 - 597, XP002046939 *
SCHOENMAKERS ET AL.: "Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma", GENOMICS, vol. 20, no. 2, 15 March 1994 (1994-03-15), pages 210 - 222, XP002046940 *

Also Published As

Publication number Publication date
WO1997038083A2 (en) 1997-10-16
EP0927194A2 (en) 1999-07-07
AU2383897A (en) 1997-10-29

Similar Documents

Publication Publication Date Title
CA2172513A1 (en) Aminocyclohexylesters and uses thereof
AU9795098A (en) 2,3-benzodiazepin-2-one derivatives, their preparation and their use as inhibi tors of protein tyrosine kinases
AU5456494A (en) Fluid cooled electrosurgical probe
AU7256094A (en) Endoscopic bipolar electrocautery instruments
AU1448595A (en) Prostatic drug-delivery catheter
AU4299496A (en) Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions
AU1927595A (en) The use of organic solvents in the synthesis of v6o13+x{0$m(f)x$m(f)2.0}
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
CA2268954A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
CA2387873A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
CA2257010A1 (en) Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
AU2291097A (en) Novel phenanthridines substituted in the 6 position
PL321343A1 (en) Novel derivatives of insulin, novl complexes, pharmaceutic agent and novel proinsulins
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU6683296A (en) Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
WO1993023549A3 (en) Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors
AU4328397A (en) Human polyhomeotic 1 ((hph1)) acts as an oncogene
WO1997001359A3 (en) Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
AR244941A1 (en) Compound, composition, procedure and use of an anti microbial product.
CA2260971A1 (en) New bis-platinum complexes with polyamine ligands as antitumor agents
CA2114859A1 (en) Cytotoxic and antiviral compound
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
WO1997038083A3 (en) New member of the multiple-tumor aberrant growth gene family
EP0237829A3 (en) Tetrahydro-3,4-furandiamine-n-n'-platinum complexes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

WWE Wipo information: entry into national phase

Ref document number: 1997919321

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97535838

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997919321

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997919321

Country of ref document: EP